| | | | | | . 10 . 20 . 30 . 40 . 50 . 60 . 70 . 80 . 90 . 100 . 110 . 120 . 130 . 140 . 150 . 160 . 170 . 180 . 190 . 200 . 210 . 220 . 230 . 240 . 250 . 260 . 270 . 280 . 290 . 300 . 310 . 320 . 330 . 340 . 350 . 360 . 370 . 380 . 390 . 400 |
# |
Score |
Template |
Links and tools | %id | First |
MSKSLIVSSPGKTILFGEHAVVYGATALAAAVSLRSYCKLQTTNNNEIVIVMSDIGTERRWNLQSLPWQHVTVENVQHPASSPNLDLLQGLGELLKNEENGLIHSAMLCTLYLFTSLSSPSQGCTLTISSQVPLGAGLGSSATISVVVATSLLLAFGNIEPPSSNSLQNNKALALIEAWSFLGECCIHGTPSGIDNAVATNGGLIAFRKATAHQSAMKEFLKPKDTLSVMITDTKQPKSTKKLVQGVFELKERLPTVIDSIIDAIDGISKSAVLALTSESDKNSSAKKLGEFIVLNQKLLECLGVSHYSIDRVLQATKSIGWTKLTGAGGGGCTITLLTPECKEEEFKLCKESLLAHKNSIYDVQLGGPGVSVVTDSDSFFPQYESDFDFKKLNLLSKFNKYYI | Last |
1 | -101.000 | [I] KOG1511 Mevalonate kinase MVK/ERG12 |
ali |
100 | 1 | MSKSLIVSSPGKTILFGEHAVVYGATALAAAVSLRSYCKLQTTNNNEIVIVMSDIGTERRWNLQSLPWQHVTVENVQHPASSPNLDLLQGLGELLKNEENGLIHSAMLCTLYLFTSLSSPSQGCTLTISSQVPLGAGLGSSATISVVVATSLLLAFGNIEPPSSNSLQNNKALALIEAWSFLGECCIHGTPSGIDNAVATNGGLIAFRKATAHQSAMKEFLKPKDTLSVMITDTKQPKSTKKLVQGVFELKERLPTVIDSIIDAIDGISKSAVLALTSESDKNSSAKKLGEFIVLNQKLLECLGVSHYSIDRVLQATKSIGWTKLTGAGGGGCTITLLTPECKEEEFKLCKESLLAHKNSIYDVQLGGPGVSVVTDSDSFFPQYESDFDFKKLNLLSKFNKYYI |
404 |
2 | -59.900 | [I] KOG4519 Phosphomevalonate kinase |
ali follow.. |
16 | 1 | MSELRAFSAPGKALLAGGYLVLDKYEAFVVGLSARMHAVAHPYGSLEVRVKSKQFKDSGFIPVSIGGSKNPFIEKVIANVFSYFKPNMDDYCNRNLFVIDIFSDDAYHSQEDSVTEHRGNRRLSFHSHRIEEVPKTGLGSSAGLVTVLTTALASFFVSDLEN-----NVDKYREVIHNLAQVAHCQAQGKGSGFDVAAAAYGSIRYRRFDEEDWNITIKSNHLPSGLTLWMGDIKNGSETVKLVQKVKNWYDSHMPESLKIYTELDHANSRFMDGLSKTCQKYPEITEVRDAVATIRRSFRKITIEPPVQTSLLDDCQTLKGCLIPGAGGYDAIAVITKQD--VDLRAQTANDKRFSKVQWLDVTQADWGVRKEKDPETYLDK..................... |
451 |
3 | -59.900 | [I] COG3890 Phosphomevalonate kinase |
ali follow.. |
16 | 1 | MSELRAFSAPGKALLAGGYLVLDKYEAFVVGLSARMHAVAHPYGSLEVRVKSKQFKDSGFIPVSIGGSKNPFIEKVIANVFSYFKPNMDDYCNRNLFVIDIFSDDAYHSQEDSVTEHRGNRRLSFHSHRIEEVPKTGLGSSAGLVTVLTTALASFFVSDLEN-----NVDKYREVIHNLAQVAHCQAQGKGSGFDVAAAAYGSIRYRRFDEEDWNITIKSNHLPSGLTLWMGDIKNGSETVKLVQKVKNWYDSHMPESLKIYTELDHANSRFMDGLSKTCQKYPEITEVRDAVATIRRSFRKITIEPPVQTSLLDDCQTLKGCLIPGAGGYDAIAVITKQD--VDLRAQTANDKRFSKVQWLDVTQADWGVRKEKDPETYLDK..................... |
451 |
4 | -56.800 | [I] COG1577 Mevalonate kinase |
ali follow.. |
24 | 39 | ........................................................................................................DHLKSLVNRFVELNNITEPLAVTIQTNLPPSRGLGSSAAVAVAFVRASYDFLGK-----------SLTKEELIEKANWAEQIAHGKPSGIDTQTIVSGKPVWFQKGHA-----ETLKTLSLDGYMVVIDTGVKGSTRQAVEDVHKLCEDPQ--YMSHVKHIGKLVLRASDVI-----EHHNFEALADIFNECHADLKALTVSHDKIEQLMKIGKENGAGKLTGAGRGGSMLLLAKD---LPTAKNIVKAVEKAGAHTWIENLGG.................................... |
279 |
5 | -54.700 | [G] COG0153 Galactokinase |
ali follow.. |
15 | 18 | .PATHTIQAPGRVNLIGEHTDYNDGFVLPCAIDYQTVISCAPRDDRKVRVMAADYENQL---------------------------DEFSLDAPIVAHENYQWANYVRGVVKHLQLRNNSFGGVDMVISGNVPQGAGLSSSASLEVAVGTVLQQLYHL-----------PLDGAQIALNGQEAENQFVGCNCGIMDQLISALGKKDHALLIDCRSLGTKAVSMPKGVAVVIINSNFKRTLVGSEYNTRRLRDVTIEEFNAV-RVRHILTENARTVEAASALEQGDLKRMGELMAESHASMRDFEITVPQIDTLVEIVKAV-GVRMTGGGFGGCIVALIPEELVPAVQQAVAEQYEAKTGETFYVCKPSQGAGQC.............................. |
382 |
6 | -52.200 | [R] COG2605 Predicted kinase related to galactokinase and mevalonate kinase |
ali follow.. |
16 | 2 | ....LISRAPVRISFFGEYFLQHGGAVLATAIDKFSYVTASPFLSHLFDYSIRVSYRKVE--------------------------------------LVKNPSEMEHVVFRECLKFCGLEKDIELHNVADLPAFTGLGSSSAFTVSLLQALHSFKGE-----------FIRPLDLAYEAIYVERHLVKDKVGCQDQLMAAMGGFNLVEFRKEDDIVVSRVTMAPERHIFIVFTGIKRRAANVVEKQLKRVGDNRE----TLKLMRAMVDKGWDIL----TSNQCLSAFGELLDQAWQAKRSLGISNGDIDRIYQQGREAGGGKLLGAGAGGFMLFFAPPSVHPRLAETFKDH------QVLSVKINAPGSQII.............................. |
324 |
7 | -40.300 | [R] COG1829 Predicted archaeal kinase (sugar kinase superfamily) |
ali follow.. |
13 | 1 | ML--VRAFVPAHITAFFVPIILSGSLGAGVNLSRGTNVFISFEESLERHVHVALNGEPVKREDAKV--------------------TFHVIDKMLPQEYV---------------------GEVEVWQYFDYPTGHGFGNSGGGALGTALCLAYKFR-------------RTLLSAAKVAHEAEVLNRGGLG--DIVAQLAGGVEVRIKEGGPGVAIVDNLIV--EGFKVLTISLGRLSTREVLD-------------SDVVEKIKVEGQKSLENLLAN-------PTLETLMREARRFAEVTGLMDDELKEIAREVDKVISLPSSMIMLGKGIFAMVRNEE----VERVKELVKDLGVPYDIAEIYWGKPTVGR............................. |
296 |
8 | -26.200 | [E] COG0083 Homoserine kinase |
ali follow.. |
15 | 2 | ...SVVVYAPASIGNVSV-----GFDVLGAAVSPIDGTLLGDR------VKVEAGAEAFTLKTAG-----------------------RFVDKLPANPQENIVYDCWQVFARELEKKSVVLKPLTMTLEKNMPIGSGLGSSACSIVAALDALNQFHAS-----------PLDETELLALMGEMEGKISGSIHYDNVAPCYLGGVQLMLEELG---IISQSVPSFDDWYWVMAYPGIKVSTAEA------------AILPAQYRRQDIVAHGRYLAGFIHACHTQQPELAAKMI--KDVIAEPYREK-PGFAKARNYAASAGALATGISGSGPTLFSVCKEQAVAERVARWLEQNYVQNEFVHICRLDKQGSKVTGSE........................... |
317 |
9 | -25.700 | [Q] COG4542 Protein involved in propanediol utilization, and related proteins (includes coumermycin biosynthetic protein), possible kinase |
ali follow.. |
15 | 42 | .VHSSDALCCGT---FGE--LLQGHFLVTMPIALFARAHFIPIAGTR--------------------------------------------SVTVYPSHKVKAKRLAENLVTAL-----SATGGVLLLQSELPEGKGLASSSADLVATARSIACCFRR-----------RVRTSLIEKLMAEIEP----------SDGVMYPGVVAYQQR---ACRLLSFLGQMPPLAIVGIDEGGTVETVDYDQRRGEISTNQRAEYQELLNRA------------RIAIPWGDAATIGKIATSS-ALLHQERTPKKHLNSMLKACEATSGVIVAHSG---TMIGILLDRMAADFPRKLRSVLAR................................................ |
315 |
10 | -24.900 | [EH] COG1685 Archaeal shikimate kinase |
ali follow.. |
17 | 1 | MRGSGRASSAITIV-----NAFATGKGAAIGIELWTEARVRVTGDGEVRGKIVV------------------------------------------KGEEFKDYRLVNSVISVLREVTGEPFGVRFEIHSDIPVGKGLKSSSAAANSLTKALVEALRL-----------NIDDLSIVKLGVEAAKRAGVTITG-DACASYFGGLC-----TDNYEMEILVKREINPETVVLLIPRETVLTESL-------KGVDFSKISPFIGEALRLAISG---------------EWKKALVINGLLYST--FLGYDLAPMREALKLGAFVGLCGKG--PAFFAIADEP------EEIIEAWSSFG-DVIATSLR..................................... |
274 |
11 | -22.300 | [R] COG1907 Predicted archaeal sugar kinases |
ali follow.. |
13 | 2 | ....LRLRTPSRIHI-GSIGRVDGGVGLALE---EPHIEIKAKESETFVLKGEP-------------------------------------------------INRERFEIAAAKMAEYCGRGAEIEVVSDYDAHVGLGSGTQISLAVGRAFSELYGL-----------NLTTRQIAEIMGRGGTSGIGVAVFDHGGLVVDGGHLPSSASRAKPAPMIARLDFPDWNVVLAIPDLKGFFGEREVNLFQKSCPVPLEDVREICHLI--------LMKMLPAVVEADLDEFGKALKRIQELGFKKAEVEQYGELIKGCFDLADCIGMSSTG----TVYAITDSNAGGIERSLRDYFAEKGCRTIVTKARNRGVEIE.............................. |
312 |
12 | -20.300 | [E] KOG1537 Homoserine kinase |
ali follow.. |
12 | 2 | ..QKFQIKVPASSANIGP-----GFDVLGMSLEEYMTLDVEVSTESGPC----------------------------------VLTYEGDGKEHVSLDVQKNMITQTSLYVLRCNNISTFPYATKIHVINPIPLGRGMGSSGSAAIAGVMLANEIAKL-----------GLSKLQMMDYVLMIE----RHPDNV--MASMMGGFV--LTLPPKSLGTFARLPWASELKAIVVIPEFHLATSKA-----------RSVLPTSYGRTDVVYNLQRLALLTTALGQTPIHLVYEVMKVHQPYRASLIPGLQNILATLNPDTQPGGICLSGAG----TVLALATGNFDEIAHAMLSIFEKHGCRYLVLSPAFDGATVKY............................. |
337 |
13 | -18.100 | [I] COG1947 4-diphosphocytidyl-2C-methyl-D-erythritol 2-phosphate synthase |
ali follow.. |
14 | 2 | ...RTQWPSPAKLNLFGYHTL----QTLFQFLDYGDTISIELRDDGDIRLLTPVEGVEHEDNL--------------------------------------VRAARLLMKTAADSGRLPTGSGANISIDKRLPMXGGLGGGSSNAATVLVALNHLWQC-----------GLSMDELAEM---------GLTLGADVPVFVRGHAAFAE--------EILTPVDPPEKWYLVAHPGVSIPTPVIFKDPELPRNTPKRSIETLLKC-----------------------------EFSNDCEVIARKRFREVDAVLSWLLEYAPSRLTGTG--ACVFAEFDTESEARQVLEQAPE................................................... |
263 |
14 | -14.500 | [I] COG3407 Mevalonate pyrophosphate decarboxylase |
ali follow.. |
14 | 29 | .GEIHYGSGYPITGLIGESLKIANFPSISLNTDAYSAFMISKDNGNDTAV--------------------------------------------VEGENSPNITKKAMTAINVFKNLYDIKGSFHFYLRIKYAGAKGLGESAAVAAAASRSLVSALFEKEA--------LKDSNFISIVARLAS----GSGS------SVAGPLSLWLTAPAVSHEGSFSLNLRKEIDFLCAVPIRDSVSTAEAHNTVIKSPFYQQWSRLQFDAVYSII-----------SRGGYSAQIIENATTNTYLMHSVLISTGRAMGIVEDMRRIGRLIGFSIDTGPSVLVMADREDLIKEFKERYN.................................................... |
329 |
15 | -12.300 | [I] KOG2833 Mevalonate pyrophosphate decarboxylase |
ali follow.. |
9 | 6 | WVFMVTAQTPTNIAVI-----YWGKRDEVRILPVNDSISVT-------------LDPDHLCTVTTVAVSPAFDRDRMWLNGKEISLSGSRYQNCLREIRGRAGDVEDMEKGIKIRKKDWEKLNLHIASHNNFPTAAGLASSAAGFACLVFSLAKLMNV-----------DEDPSHLSAIARQ------GSGSAC----SLFGGFVKWTMGSKEDGSDSVAVQLADEDDLVIIIAVETSSTSGMRESVET---------SLLLQHRAKEVVPKRILQMEEAIKNRDFASFTQLTCTDSNQFHAVCLDTSPISLVEKWNRSEGTPQVA--DAGPNAVLIARNRKVAVQLLQGLLY................................................... |
328 |